Despite the effort and skill devoted to aphasia rehabilitation, we still know very little about which therapies really work, and why some patients benefit more than others. In this talk, we will demonstrate the enduring benefits of ‘clinically routine’ therapy during the first month post-stroke, and show how therapy benefits might be amplified, by showing that it is possible to predict how individual patients will respond to individual therapies. You can see a written version of this talk here.
